Muciclar (Paediatric) 2% Syrup
Carbocisteine
20mg/ml
PARKE DAVIS LABORATORIES
| Pack size | 125ml |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | NEW MEDICAL CENTRE |
| Retail Price | 7.50 AED |
Available as:
Indications
Muciclar (Paediatric) 2% Syrup is used for:
Bronchiectasis, Mucolytic, Chronic obstructive pulmonary disorder (COPD)
Adult Dose
Oral
As a mucolytic
Adult: Initially, 750 mg tid, then 1.5 g daily in divided doses.
Child Dose
Oral
As a mucolytic
Child: 2-5 yr: 62.5-125 mg 4 times daily; 6-12 yr: 250 mg tid.
Renal Dose
Administration
Should be taken with food.
Contra Indications
Active peptic ulceration.
Precautions
History of peptic ulceration.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Carbocisteine :
Nausea, gastric discomfort, GI bleeding, skin rash.
Mechanism of Action
Carbocisteine is a mucolytic. Carbocisteine reduces goblet cell hyperplasia and therefore plays a role in the management of disorders characterised by abnormal mucous.
Note
Muciclar (Paediatric) 2% 20mg/ml Syrup manufactured by PARKE DAVIS LABORATORIES. Its generic name is Carbocisteine. Muciclar (Paediatric) 2% is availble in United Arab Emirates.
Farmaco UAE drug index information on Muciclar (Paediatric) 2% Syrup is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.